Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection

NCT04392232 is registered in ClinicalTrials.gov with TriHealth Inc. as lead sponsor.

NCT NCT04392232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04392232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
Lead sponsor
TriHealth Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 5, 2020
Completion date
September 21, 2021
Enrollment
159 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

convalescent plasma, coronavirus, covid-19